13F filing recap · Q2 2017

What did Pzena Investment Management buy in Q2 2017?

Reported stock-position changes between this filing and the previous one.

Stock value

$18.26B

Positions

152

Estimated turnover

8.9%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ESRXExpress Scripts Holding Co$181.23Mreported value+2.84M shares ROCKGibraltar Industries, Inc.$28.29Mreported value+793.7K shares DXCDxc Technology Co$13.01Mreported value+169.5K shares OHIOmega Healthcare Investors, Inc.$340.0Kreported value+10.3K shares ZBHZimmer Biomet Holdings, Inc.$260.0Kreported value+2.0K shares

Increased positions

ORCLOracle Corporation$504.67Mreported value+21.3K shares+0.2%OMCOmnicom Group Inc.$495.66Mreported value+1.05M shares+21.3%MYLMylan N.v.$479.03Mreported value+5.08M shares+69.9%VOYAVoya Financial, Inc.$473.12Mreported value+23.5K shares

Reduced positions

CCitigroup Inc$559.54Mreported value-25.4K shares-0.3%BACBank of America Corp$497.10Mreported value-902.7K shares-4.2%MSMorgan Stanley$405.71Mreported value-112.1K shares-1.2%JPMJPMorgan Chase & Co$379.71Mreported value-15.2K shares

Exited positions

CDWCdw Corp$9.27Mprior reported value-160.6K shares-100.0%BPOPPopular, Inc.$4.04Mprior reported value-99.3K shares-100.0%EEMIshares, Inc.$2.64Mprior reported value-66.9K shares-100.0%INFYInfosys Limited$1.81Mprior reported value-114.7K shares